Approval · Notice of Compliance 18755 · 2016
AFSTYLA: Notice of Compliance 18755
Issued December 12, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18755
- Date
- December 12, 2016
- Company
- Csl Behring Canada IncOttawa, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AFSTYLA | Not yet assigned | — |
Medicinal ingredients
- LONOCTOCOG ALFA 250 UNIT per VIAL
- LONOCTOCOG ALFA 375 UNIT per VIAL
- LONOCTOCOG ALFA 500 UNIT per VIAL
- LONOCTOCOG ALFA 1,000 UNIT per VIAL
- LONOCTOCOG ALFA 1,500 UNIT per VIAL
- LONOCTOCOG ALFA 2,000 UNIT per VIAL
- LONOCTOCOG ALFA 2,500 UNIT per VIAL
- LONOCTOCOG ALFA 3,000 UNIT per VIAL